Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cost-effectiveness
100%
Cardiac Resynchronization Therapy
100%
Symptomatic Heart Failure
100%
Quality-adjusted Life Years
60%
Medical Therapy
40%
Incremental Cost-effectiveness Ratio
40%
Incremental Cost
40%
Illness
20%
Hospitalization
20%
Relative Risk
20%
Sensitivity Analysis
20%
Ejection Fraction
20%
Heart Failure
20%
Health-related Quality of Life
20%
Monte Carlo Simulation
20%
Ventricular Function
20%
Patients with Heart Failure
20%
Several Variables
20%
Life Expectancy
20%
Exclusion Criteria
20%
Ventricular Contractility
20%
Cost Data
20%
Resynchronization Therapy
20%
Markov Model
20%
Cardiac Resynchronization
20%
Lifetime Cost
20%
Resynchronization
20%
Publicly Available Data
20%
Long-term Costs
20%
Long-term Morbidity
20%
Source Effects
20%
US Healthcare System
20%
Life Data
20%
Comorbid Conditions
20%
Cost per Quality-adjusted Life Year
20%
Nursing and Health Professions
Congestive Heart Failure
100%
Cardiac Resynchronization Therapy
100%
Quality Adjusted Life Year
66%
Diseases
33%
Base
16%
Heart Ejection Fraction
16%
Systematic Review
16%
Healthcare System
16%
Morbidity
16%
Life Expectancy
16%
Patient Population
16%
Quality of Life
16%
Monte Carlo Method
16%